Echo IQ is trading at A$0.59 (-11.94%), with no clear company-specific catalyst identified for the September 25 move.
- The available ASX announcement listing shows no newer announcement than August 28 in its displayed results.
- The earlier FDA update on EchoSolv HF is prior context, not evidence of a cause for the decline.
- Supplied market indices were unchanged; September 25 is identified as the last trading session.